You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 16, 2024

Fougera Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for FOUGERA, and what generic and branded alternatives to FOUGERA drugs are available?

FOUGERA has one hundred and twelve approved drugs.

Summary for Fougera

US Patents:	0
Tradenames:	53
Ingredients:	45
NDAs:	112

Drugs and US Patents for Fougera

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Fougera Pharms Inc	FLUOCINONIDE	fluocinonide	SOLUTION;TOPICAL	072934-001	Feb 27, 1995	AT	RX	No	No		⤷ Sign Up				⤷ Sign Up
Fougera Pharms	METRONIDAZOLE	metronidazole	LOTION;TOPICAL	077197-001	May 24, 2006	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
Fougera	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	CREAM;VAGINAL	086424-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Sign Up				⤷ Sign Up
Fougera Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	CREAM;TOPICAL	085692-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Fougera Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	OINTMENT;TOPICAL	085691-003	Approved Prior to Jan 1, 1982	AT	RX	No	No		⤷ Sign Up				⤷ Sign Up
Fougera Pharms	TEMOVATE E	clobetasol propionate	CREAM;TOPICAL	020340-001	Jun 17, 1994		DISCN	Yes	No		⤷ Sign Up				⤷ Sign Up
Fougera Pharms Inc	ACYCLOVIR	acyclovir	OINTMENT;TOPICAL	206633-001	May 11, 2016	AB	RX	No	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Fougera

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Fougera Pharms	CUTIVATE	fluticasone propionate	OINTMENT;TOPICAL	019957-001	Dec 14, 1990	4,335,121*PED	⤷ Sign Up
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,792,753	⤷ Sign Up
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,852,002	⤷ Sign Up
Fougera Pharms	ACLOVATE	alclometasone dipropionate	CREAM;TOPICAL	018707-001	Dec 14, 1982	4,124,707	⤷ Sign Up
Fougera Pharms	SOLARAZE	diclofenac sodium	GEL;TOPICAL	021005-001	Oct 16, 2000	5,914,322	⤷ Sign Up
Fougera Pharms	ACLOVATE	alclometasone dipropionate	OINTMENT;TOPICAL	018702-001	Dec 14, 1982	4,124,707	⤷ Sign Up
Fougera Pharms	TEMOVATE	clobetasol propionate	CREAM;TOPICAL	019322-001	Dec 27, 1985	3,721,687	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for FOUGERA drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Topical Gel	3%	➤ Subscribe	2009-12-16
➤ Subscribe	Lotion	0.05%	➤ Subscribe	2008-07-28

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.